Francisco Purroy Selected Research

Francisco Purroy Research Topics

31	Stroke (Strokes) 04/2024 - 07/2005
11	Ischemic Stroke 04/2024 - 07/2005
6	Transient Ischemic Attack 01/2023 - 10/2012
4	Inflammation (Inflammations) 04/2024 - 01/2020
4	Prediabetic State (Prediabetes) 03/2022 - 11/2019
3	Coronary Disease (Coronary Heart Disease) 01/2023 - 02/2012
3	Ischemia 12/2021 - 07/2018
3	Embolic Stroke 06/2021 - 05/2015
3	Hemorrhage 01/2018 - 02/2014
2	Infarction (Infarctions) 11/2021 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 10/2021 - 07/2018
2	Diabetes Mellitus 10/2021 - 02/2014
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020 - 10/2019
2	Hypertension (High Blood Pressure) 01/2017 - 01/2016
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016 - 01/2016
2	Atherosclerosis 01/2015 - 12/2007
2	Cerebral Hemorrhage 02/2014 - 10/2012
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2023
1	Cerebral Infarction 01/2023
1	Hyperglycemia 03/2022
1	Lung Diseases (Lung Disease) 03/2022
1	Renal Insufficiency (Renal Failure) 10/2021
1	Seizures (Absence Seizure) 04/2021
1	Obesity 03/2021
1	Disease Progression 02/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2018
1	Cognitive Dysfunction 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Leukoaraiosis 01/2018
1	Siderosis 01/2018
1	Vascular Malformations 01/2016
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2013
1	Acute Coronary Syndrome 10/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2013
1	Peripheral Arterial Disease 02/2012
1	Hypercholesterolemia 02/2012
1	Carotid Artery Diseases 02/2006

8	Biomarkers (Surrogate Marker)IBA 11/2023 - 07/2013
4	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2022 - 07/2005
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2022 - 11/2019
2	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 11/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 10/2013
2	AnticoagulantsIBA 01/2018 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 02/2014
2	danaparoid (Orgaran)FDA Link 06/2013 - 12/2007
1	Fibrinogen (Factor I)FDA Link 04/2024
1	C-Reactive ProteinIBA 01/2023
1	Advanced Glycation End ProductsIBA 03/2022
1	Syntex adjuvant formulationIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	BarbituratesIBA 12/2021
1	Anesthetics (Anesthetic Agents)IBA 12/2021
1	InterleukinsIBA 06/2021
1	Colchicine FDA LinkGeneric 06/2021
1	Tubulin ModulatorsIBA 06/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Cytochrome P-450 CYP2C9IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	AcenocoumarolIBA 01/2020
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Uric Acid (Urate)IBA 11/2018
1	1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA 01/2018
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2018
1	Natriuretic PeptidesIBA 05/2015
1	pro-brain natriuretic peptide (1-76)IBA 05/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2015
1	Blood Glucose (Blood Sugar)IBA 02/2014

12	Therapeutics 04/2024 - 02/2012
7	Secondary Prevention 04/2024 - 05/2015
7	Thrombectomy 04/2023 - 01/2014
2	General Anesthesia 01/2023 - 10/2021
2	Contraindications 11/2022 - 01/2014
2	Punctures 10/2021 - 01/2016
2	Time-to-Treatment 01/2016 - 02/2006
1	Ambulatory Care (Outpatient Care) 01/2017
1	Thrombolytic Therapy 10/2012
1	Microbubbles 02/2006